Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals ≥18 years of age will be enrolled.~* Patients must have histologic confirmation of a solid tumor malignancy that will be treated with a regimen that contains full-dose oxaliplatin.~* Patients may be receiving treatment in the neoadjuvant, adjuvant or metastatic setting.~* Patients must be treatment-naïve to platinum-agents at the time of enrollment. Prior treatment with non-platinum agents is permitted.~Exclusion Criteria:~* Any active intraoral infection, including yeast infection (thrush) or active oral herpes simplex virus at the time of enrollment.~* Patients may not have dentures.~* Patients may not have a disorder that may result in altered taste sensation at baseline. This includes but is not limited to: persistent dry mouth.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: EXPERIMENTAL): will be treated with consistent exposure to oral ice
- Arm B (Type: ACTIVE_COMPARATOR): Will not be treated with consistent exposure to oral ice.

Based on this trial design, predict the completion outcome and termination type (if applicable).